These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 14082331)
21. Interpretation and reporting of prothrombin activity; including a method of converting prothrombin time to percentage of prothrombin activity. BRONSTEIN MR J Med Soc N J; 1952 Dec; 49(12):511-4. PubMed ID: 13011602 [No Abstract] [Full Text] [Related]
22. Recombinant human prothrombin reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding. Hansson KM; Johansson KJ; Wingren C; Fries D; Nelander K; Lövgren A Blood Coagul Fibrinolysis; 2017 Apr; 28(3):244-253. PubMed ID: 27428015 [TBL] [Abstract][Full Text] [Related]
23. The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test. MANCHESTER B; RABKIN B Circulation; 1954 Nov; 10(5):691-8. PubMed ID: 13209750 [No Abstract] [Full Text] [Related]
24. [Thrombin equivalent of prothrombin units and a modified 2-stage measurement of prothrombin]. KOWARZYK H; MARCINIAKOWNA E; KOTSCHY M; CZERWINSKA B Postepy Hig Med Dosw; 1960; 14():95-100. PubMed ID: 14411498 [No Abstract] [Full Text] [Related]
25. [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1]. FORELL MM; KOLLER F Munch Med Wochenschr; 1953 Apr; 95(15):433-7. PubMed ID: 13072403 [No Abstract] [Full Text] [Related]
26. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma. Mischke R; Wolling H Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962 [TBL] [Abstract][Full Text] [Related]
27. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin]. SOULIER JP; LARRIEU MJ Sang; 1952; 23(7):549-59. PubMed ID: 13004906 [No Abstract] [Full Text] [Related]
28. BLOOD COAGULATION: PRACTICAL SIGNIFICANCE OF RECENT ADVANCES IN KNOWLEDGE OF PROTHROMBIN. SEEGERS WH Tex State J Med; 1963 Nov; 59():1068-75. PubMed ID: 14084901 [No Abstract] [Full Text] [Related]
29. TIMING PLATELET AGGREGATION USING AN E.E.L. PROTHROMBIN METER. COOK IJ; SYMONS C Lancet; 1965 Jun; 1(7397):1198-9. PubMed ID: 14288562 [No Abstract] [Full Text] [Related]
30. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin]. LONG LA; COLPRON G Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333 [No Abstract] [Full Text] [Related]
31. A factor in serum which accelerates the conversion of prothrombin to thrombin; its evolution with special reference to the influence of conditions which affect blood coagulation. ALEXANDER B; DE VRIES A; GOLDSTEIN R Blood; 1949 Jun; 4(6):739-46. PubMed ID: 18129759 [No Abstract] [Full Text] [Related]
32. A factor in serum which accelerates the conversion of prothrombin to thrombin; its relationship to the coagulation defect of thrombocytopenic blood. ALEXANDER B; DE VRIES A Blood; 1949 Jun; 4(6):747-51. PubMed ID: 18129760 [No Abstract] [Full Text] [Related]
33. Inhibitor of human blood coagulation elicited by thrombin. Marciniak E J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460 [No Abstract] [Full Text] [Related]
34. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube. d'Audigier C; Delassasseigne C; Robert A; Eschwège V Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495 [TBL] [Abstract][Full Text] [Related]
35. Effective reversal of edoxaban-associated bleeding with four-factor prothrombin complex concentrate in a rabbit model of acute hemorrhage. Herzog E; Kaspereit F; Krege W; Doerr B; Mueller-Cohrs J; Pragst I; Morishima Y; Dickneite G Anesthesiology; 2015 Feb; 122(2):387-98. PubMed ID: 25419685 [TBL] [Abstract][Full Text] [Related]
36. The coagulation defect in hemophilia with particular reference to the conversion of prothrombin to thrombin and the evolution of the prothrombin conversion accelerator. ALEXANDER B; DE VRIES A Blood; 1949 Jun; 4(6):752-8. PubMed ID: 18129761 [No Abstract] [Full Text] [Related]
37. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT. REILLY EB; GOODMAN JR; WARNER GF Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485 [TBL] [Abstract][Full Text] [Related]
38. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY. SEVITT S; INNES D Lancet; 1964 Jan; 1(7325):124-9. PubMed ID: 14074476 [No Abstract] [Full Text] [Related]
39. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)]. DE NICOLA P; ZANGAGLIA O; SOARDI F Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944 [No Abstract] [Full Text] [Related]
40. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS]. MATTIOLI G; RABITTI G; NAVA C Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]